Back to announcement
Surat Pernyataan Direksi untuk LK e sign dirut-r.pdf
Financial statement Text extracted INAFSource file signed link, expires in 15 minutes
Extracted text 1
Page 1 OCR 0.892
SURAT PERNYATAAN DIREKSI TENTANG TANGGUNG JAWAB ATAS LAPORAN KEUANGAN TANGGATI, 30 SEPTEMBER 2025 DAN UNTUK PERIODE SEMBILAN BULAN YANG BERAKHIR PADA TANGGAL TERSEBUT PT INDOFARMA Tbk Kami yang bertanda tangan di bawah ini: (/ indofarma Member of Biofarma Graup DIRECTORS' STATEMENT LETTER REGARDING TINE RESPONSIBILITY FOR THE FINANCIAL STATEMENTIS AS OF SEPTEMBER 30, 2025 AND FOR THE NINE-MONTH PERIOD THEN ENDED PT INDOFARMA Tbk We, Ihe undersigned : Nama Sahat Sihombing Name Alamat Kantor Jl. Indofarma No. 1, Cikarang Barat 17530 Official Address NIK 3175022310660002 ID Number Jabatan Direktur Utama / President Director Position Menyatakan bahwa : I. Kami bertanggung jawab atas penyusunan dan penyajian laporan keuangan PT Indofarma Tbk, 2. Laporan keuangan PT Indofarma Tbk telah disusun dan disajikan sesuai dengan Standar Akuntansi Keuangan di Indonesia: Semua informasi dalam laporan kenangan PT Indofarma Tbk telah dimuat secara lengkap dan benar: b. Laporan keuangan PT Indofarma Tbk tidak mengandung informasi atau fakta material yang tidak benar, dan tidak menghilangkan informasi atau fakta material: 4. Kami bertanggung jawab atas sistem pengendalian internal dalam PT Indofarma Tbk. Demikian pernyataan ini dibuat dengan sebenarnya. State that : 1 3. We are responsible for preparation and presentation of" Ihe financial statements of PT Indofarma Tbk: The financial statements of PT Indofarma Tbk have been prepared and presented in accordance with Indonesian Financial Accounting Standards: a. All information contained in Ihe financial statements of PT Indofarma Tbk is complete and correct, b. The financial statements of PT Indofarma Tbk do not contain misleading material information or facts, and do not omit material information and facts: We are responsible for Ihe internal control system of PT' Indofarma Tbk. This statemeni letter is made truthfully. Jakarta, 28 Oktober 2025 / October 28, 2025 PT Indofarma Tbk Direktur Utama / Prefident Director Y TAN, XO70575723 Ae PT Indofarma Tbk JL. Indofarma No.1, Cikarang Barat Bekasi 17530 - Indonesia Ph. G2-21-88323971/75 Fx. 62-21-88323972/73 Email: headoffice@indofarma.id www.indofarma.id
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.